On December 29, 2025, Theriva Biologics Inc (AMEX: TOVX) opened at $0.23, higher 2.40% from the last session. During the day, the shares moved up to $0.23 and dropped to $0.18 before settling in for the closing price of $0.19. Price fluctuations for TOVX have ranged from $0.17 to $2.03 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 39.99% over the past five years. Company’s average yearly earnings per share was noted 80.61% at the time writing. With a float of $32.97 million, this company’s outstanding shares have now reached $33.74 million.
Theriva Biologics Inc (TOVX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Theriva Biologics Inc is 2.27%, while institutional ownership is 1.30%.
Theriva Biologics Inc (TOVX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -11.49 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -7.22) by -4.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.81% during the next five years compared to 39.99% growth over the previous five years of trading.
Theriva Biologics Inc (AMEX: TOVX) Trading Performance Indicators
Check out the current performance indicators for Theriva Biologics Inc (TOVX). In the past quarter, the stock posted a quick ratio of 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.54, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.28 in one year’s time.
Technical Analysis of Theriva Biologics Inc (TOVX)
Theriva Biologics Inc (AMEX: TOVX) saw its 5-day average volume 27.74 million, a positive change from its year-to-date volume of 5.06 million. As of the previous 9 days, the stock’s Stochastic %D was 46.86%.
During the past 100 days, Theriva Biologics Inc’s (TOVX) raw stochastic average was set at 4.41%, which indicates a significant decrease from 43.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0212 in the past 14 days, which was lower than the 0.0413 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2560, while its 200-day Moving Average is $0.5536. Nevertheless, the first resistance level for the watch stands at $0.2209 in the near term. At $0.2458, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2649. If the price goes on to break the first support level at $0.1769, it is likely to go to the next support level at $0.1578. Assuming the price breaks the second support level, the third support level stands at $0.1329.
Theriva Biologics Inc (AMEX: TOVX) Key Stats
There are currently 33,740K shares outstanding in the company with a market cap of 6.61 million. Presently, the company’s annual sales total 0 K according to its annual income of -25,650 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -4,360 K.
